CCR5 is highly expressed in glioblastomas and can trigger the PI3K/AKT pathway to promote proliferation, induce polarization of TAMs and immune suppression and facilitate the maintenance of glioma stem-like features [28]. The gene discussed is CCR5; the disease is central nervous system cancer.